Log in

Caffeine toxicity in forensic practice: possible effects and under-appreciated sources

  • Review
  • Published:
Forensic Science, Medicine, and Pathology Aims and scope Submit manuscript

Abstract

Caffeine is considered a very safe stimulant and is widely consumed in a variety of forms, from pure caffeine to beverages and foods. Typically, death is only seen when gram quantities of caffeine are consumed, usually in suicide attempts. Even in this scenario, death is rare. However, there are special populations that need to be considered in forensic presentations, who may be at greater risk. These include poor metabolizers, people with liver disease, and people with cardiac conditions, who can die as a result of caffeine intake at levels well below what is ordinarily considered toxic. Also, caffeine intake may be hidden. For example, herbal medicines with substantial caffeine content may not disclose these concentrations on their product label. The role of caffeine in medicolegal deaths is yet to be defined, however, herbal medicines and herbal weight loss supplements may represent an underappreciated source of caffeine in this context.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Panel EN. Scientific opinion on the safety of caffeine. EFSA J. 2015;13:120.

    Google Scholar 

  2. Dalvi RR. Acute and chronic toxicity of caffeine: a review. Vet Hum Toxicol. 1986;28:144–50.

    CAS  PubMed  Google Scholar 

  3. Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol. 2014;180:763–75.

    Article  PubMed  Google Scholar 

  4. Loftfield E, Freedman ND, Graubard BI, Guertin KA, Black A, Huang WY, et al. Association of Coffee consumption with overall and cause-specific mortality in a large US prospective cohort study. Am J Epidemiol. 2015;182:1010–22.

    PubMed  Google Scholar 

  5. Boison D. Methylxanthines, seizures, and excitotoxicity. Handb Exp Pharmacol. 2011;200:251–66.

    Article  CAS  PubMed  Google Scholar 

  6. Schimpl FC, da Silva JF, Goncalves JF, Mazzafera P. Guarana: revisiting a highly caffeinated plant from the Amazon. J Ethnopharmacol. 2013;150:14–31.

    Article  CAS  PubMed  Google Scholar 

  7. Tunnicliffe JM, Erdman KA, Reimer RA, Lun V, Shearer J. Consumption of dietary caffeine and coffee in physically active populations: physiological interactions. Appl Physiol Nutr Metab. 2008;33:1301–10.

    Article  CAS  PubMed  Google Scholar 

  8. Gunja N, Brown JA. Energy drinks: health risks and toxicity. Med J Aust. 2012;196:46–9.

    Article  PubMed  Google Scholar 

  9. Pendleton M, Brown S, Thomas CM, Odle B. Potential toxicity of caffeine when used as a dietary supplement for weight loss. J Diet Suppl. 2013;10:1–5.

    Article  CAS  PubMed  Google Scholar 

  10. Cannon ME, Cooke CT, McCarthy JS. Caffeine-induced cardiac arrhythmia: an unrecognised danger of healthfood products. Med J Aust. 2001;174:520–1.

    CAS  PubMed  Google Scholar 

  11. Banerjee P, Ali Z, Levine B, Fowler DR. Fatal caffeine intoxication: a series of eight cases from 1999 to 2009. J Forensic Sci. 2014;59:865–8.

    Article  CAS  PubMed  Google Scholar 

  12. Bonsignore A, Sblano S, Pozzi F, Ventura F, Dell’Erba A, Palmiere C. A case of suicide by ingestion of caffeine. Forensic Sci Med Pathol. 2014;10:448–51.

    Article  PubMed  Google Scholar 

  13. Jabbar SB, Hanly MG. Fatal caffeine overdose: a case report and review of literature. Am J Forensic Med Pathol. 2013;34:321–4.

    Article  PubMed  Google Scholar 

  14. Silva AC, de Oliveira Ribeiro NP, de Mello Schier AR, Pereira VM, Vilarim MM, Pessoa TM, et al. Caffeine and suicide: a systematic review. CNS Neurol Disord: Drug Targets. 2014;13:937–44.

    Article  CAS  Google Scholar 

  15. Yamamoto T, Yoshizawa K, Kubo S, Emoto Y, Hara K, Waters B, et al. Autopsy report for a caffeine intoxication case and review of the current literature. J Toxicol Pathol. 2015;28:33–6.

    Article  PubMed  Google Scholar 

  16. Dorne JL, Walton K, Renwick AG. Uncertainty factors for chemical risk assessment: human variability in the pharmacokinetics of CYP1A2 probe substrates. Food Chem Toxicol. 2001;39:681–96.

    Article  CAS  PubMed  Google Scholar 

  17. Kashuba AD, Bertino JS Jr, Kearns GL, Leeder JS, James AW, Gotschall R, et al. Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenoty**. Clin Pharmacol Ther. 1998;63:540–51.

    Article  CAS  PubMed  Google Scholar 

  18. Wang L, Hu Z, Deng X, Wang Y, Zhang Z, Cheng ZN. Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers. Basic Clin Pharmacol Toxicol. 2013;112:257–63.

    Article  CAS  PubMed  Google Scholar 

  19. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006;295:1135–41.

    Article  CAS  PubMed  Google Scholar 

  20. Yang A, Palmer AA, de Wit H. Genetics of caffeine consumption and responses to caffeine. Psychopharmacology. 2010;211:245–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Busuttil M, Willoughby S. A survey of energy drink consumption among young patients presenting to the emergency department with the symptom of palpitations. Int J Cardiol. 2016;204:55–6.

    Article  PubMed  Google Scholar 

  22. Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol. 2008;64:1147–61.

    Article  CAS  PubMed  Google Scholar 

  23. Cheston P, Smith L. Man died after overdosing on caffeine mints. Independent. 2013.

  24. Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet. 2000;39:127–53.

    Article  CAS  PubMed  Google Scholar 

  25. George J, Murphy T, Roberts R, Cooksley WG, Halliday JW, Powell LW. Influence of alcohol and caffeine consumption on caffeine elimination. Clin Exp Pharmacol Physiol. 1986;13:731–6.

    Article  CAS  PubMed  Google Scholar 

  26. Ciszowski K, Biedron W, Gomolka E. Acute caffeine poisoning resulting in atrial fibrillation after guarana extract overdose. Przegl Lek. 2014;71:495–8.

    PubMed  Google Scholar 

  27. Bryczkowski C, Geib AJ. Combined butalbital/acetaminophen/caffeine overdose: case files of the Robert Wood Johnson Medical School Toxicology Service. J Med Toxicol. 2012;8:424–31.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Berger AJ, Alford K. Cardiac arrest in a young man following excess consumption of caffeinated “energy drinks”. Med J Aust. 2009;190:41–3.

    PubMed  Google Scholar 

  29. Rhidian R. Running a risk? Sport supplement toxicity with ephedrine in an amateur marathon runner, with subsequent rhabdomyolysis. BMJ Case Rep. 2011. doi:10.1136/bcr.11.2011.5093.

    PubMed  PubMed Central  Google Scholar 

  30. Berger RE, Ganetsky M. An over-the-counter weight-loss supplement with a toxicity that may be unexpectedly difficult to treat. Intern Emerg Med. 2012;7(Suppl 2):S91–2.

    Article  PubMed  Google Scholar 

  31. Seifert SM, Seifert SA, Schaechter JL, Bronstein AC, Benson BE, Hershorin ER, et al. An analysis of energy-drink toxicity in the National Poison Data System. Clin Toxicol (Phila). 2013;51:566–74.

    Article  Google Scholar 

  32. Wolk BJ, Ganetsky M, Babu KM. Toxicity of energy drinks. Curr Opin Pediatr. 2012;24:243–51.

    Article  CAS  PubMed  Google Scholar 

  33. Yen M, Ewald MB. Toxicity of weight loss agents. J Med Toxicol. 2012;8:145–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Campana C, Griffin PL, Simon EL. Caffeine overdose resulting in severe rhabdomyolysis and acute renal failure. Am J Emerg Med. 2014;32:111.e3–.e4.

    Article  Google Scholar 

  35. Chiang WF, Liao MT, Cheng CJ, Lin SH. Rhabdomyolysis induced by excessive coffee drinking. Hum Exp Toxicol. 2014;33:878–81.

    Article  PubMed  Google Scholar 

  36. Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Bellis M. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal. 2011;3:89–96.

    Article  CAS  PubMed  Google Scholar 

  37. Davies S, Lee T, Ramsey J, Dargan PI, Wood DM. Risk of caffeine toxicity associated with the use of ‘legal highs’ (novel psychoactive substances). Eur J Clin Pharmacol. 2012;68:435–9.

    Article  CAS  PubMed  Google Scholar 

  38. Hoyte C. The toxicity of energy drinks: myth or reality? Clin Toxicol (Phila). 2013;51:729–30.

    Article  CAS  Google Scholar 

  39. O’Malley PA. Caffeinated energy drinks: risks assumed with consumption when competing, working, and drinking. Clin Nurse Spec. 2012;26:250–3.

    Article  PubMed  Google Scholar 

  40. Suzuki H, Tanifuji T, Abe N, Maeda M, Kato Y, Shibata M, Fukunaga T. Characteristics of caffeine intoxication-related death in Tokyo, Japan, between 2008 and 2013. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2014;49:270–7.

    PubMed  Google Scholar 

  41. Ishikawa T, Yuasa I, Endoh M. Non specific drug distribution in an autopsy case report of fatal caffeine intoxication. Leg Med (Tokyo). 2015;17:535–8.

    Article  CAS  Google Scholar 

  42. Tominaga M, Michiue T, Oritani S, Ishikawa T, Maeda H. Evaluation of postmortem drug concentrations in bile compared with blood and urine in forensic autopsy cases. J Anal Toxicol. 2016;40:367–73.

    Article  PubMed  Google Scholar 

  43. Tominaga M, Michiue T, Ishikawa T, Inamori-Kawamoto O, Oritani S, Maeda H. Evaluation of postmortem drug concentrations in cerebrospinal fluid compared with blood and pericardial fluid. Forensic Sci Int. 2015;254:118–25.

    Article  CAS  PubMed  Google Scholar 

  44. Byard RW. The potential forensic significance of traditional herbal medicines. J Forensic Sci. 2010;55:89–92.

    Article  PubMed  Google Scholar 

  45. Ozdemir B, Sahin I, Kapucu H, Celbis O, Karakoc Y, Erdogan S, et al. How safe is the use of herbal weight-loss products sold over the internet? Hum Exp Toxicol. 2013;32:101–6.

    Article  CAS  PubMed  Google Scholar 

  46. Khazan M, Hedayati M, Kobarfard F, Askari S, Azizi F. Identification and determination of synthetic pharmaceuticals as adulterants in eight common herbal weight loss supplements. Iran Red Crescent Med J. 2014;16:e15344.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ian F. Musgrave.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Musgrave, I.F., Farrington, R.L., Hoban, C. et al. Caffeine toxicity in forensic practice: possible effects and under-appreciated sources. Forensic Sci Med Pathol 12, 299–303 (2016). https://doi.org/10.1007/s12024-016-9786-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12024-016-9786-9

Keywords

Navigation